✉news TechnologyTechnology first seen 11 h ago, last 10 h ago, peak #17

Ruanyun Edai Licenses Cogni AI to BioNexus Gene Lab for Malaysia

Original: Ruanyun Edai Technology Announces Definitive Agreement to License Cogni AI to BioNexus Gene Lab for Malaysian Healthcare Market

Ruanyun Edai Technology has announced a definitive agreement to license its Cogni AI platform to BioNexus Gene Lab for use in Malaysia's healthcare market. The deal would place the AI technology into Malaysian medical settings through BioNexus Gene Lab's operations. Details on the financial terms and timeline of the agreement have not been disclosed, and reaction to the announcement remains limited so far.

Why now: The newly announced licensing deal signals expansion of Chinese AI healthcare technology into Southeast Asia, drawing investor and industry attention.

Ruanyun Edai TechnologyBioNexus Gene LabCogni AIMalaysia

Open on news →

Evidence

• Ruanyun Edai Technology Announces Definitive Agreement to License Cogni AI to BioNexus Gene Lab for Malaysian Healthcare Market · quiverquant.com

API: https://socialmediatrends-api.osmike.com/v1/trends/1114968